BIO thrax vaccine
Ended Purchase Order Awarded Last action
- Contract number
- 75D30126P20965
- Awardee
-
Emergent Biodefense Operations Lansing LLC UEI MUM1EGCDWZJ4
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $2,825
Award facts
- Opportunity
-
- 75D30126Q78931 Solicitation number
- Contract value 100% obligated
- $2,825.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Lansing, MI 48906, USA
Award details come from SAM.gov/FPDS.
About this award
The Centers for Disease Control and Prevention, Pittsburgh division, awarded a purchase order to Emergent Biodefense Operations Lansing LLC for $2,825.20 on April 10, 2026, with ultimate completion on April 15, 2026. The order is for Bio Thrax vaccine, performed at the awardee's facility in Lansing, Michigan. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract 75D30126P20965?
75D30126P20965 was awarded to Emergent Biodefense Operations Lansing LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 10, 2026.
How much is contract 75D30126P20965 worth?
The government has obligated $2,825 on 75D30126P20965.
Was contract 75D30126P20965 competed?
The extent of competition for 75D30126P20965 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award